TTI-101 targets the pY-peptide binding pocket within the Src-homology (SH) 2 domain of STAT3 [11,53,58] and was shown to target STAT3 in mouse models for inflammation, fibrosis, and cancer [11,53,56,59,60,61,62,63,64,65,66]. The gene discussed is STAT3; the disease is cancer.